By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


KaloBios Pharmaceuticals, Inc. 

260 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-243-3100 Fax: 650-243-3260



Company News
KaloBios (KBIO) Submits IND Application For Benznidazole To FDA 5/30/2017 10:36:50 AM
KaloBios (KBIO) To Host Company Overview Webinar On May 10 5/3/2017 9:57:18 AM
KaloBios (KBIO) Release: Benznidazole On Track In Progress To IND And NDA Submissions 4/6/2017 11:21:54 AM
KaloBios (KBIO) Announces Positive Guidance From FDA For Benznidazole 1/6/2017 8:52:44 AM
KaloBios (KBIO) Completes Meeting With FDA For Benznidazole 12/12/2016 7:43:48 AM
KaloBios (KBIO) Highlights Priority Milestones In Letter To Stakeholders 12/5/2016 8:29:25 AM
KaloBios (KBIO) CEO To Participate In Pharmaceutical Strategy Conference 9/27/2016 7:41:42 AM
KaloBios (KBIO) Now Current On SEC Periodic Filings 9/26/2016 7:58:41 AM
KaloBios (KBIO) Files Outstanding 10-Q And 10-K for 2015 9/2/2016 8:06:37 AM
KaloBios (KBIO), Post-Shkreli, Vows 'Maniacal' Focus On R&D And Transparency 8/30/2016 7:07:58 AM